Voyager Therapeutics Future Growth
Future criteria checks 0/6
Key information
-24.1%
Earnings growth rate
-13.8%
EPS growth rate
Biotechs earnings growth | 30.3% |
Revenue growth rate | -11.0% |
Future return on equity | -27.0% |
Analyst coverage | Good |
Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 09Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S
Aug 08Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis
Jun 05There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise
Mar 15Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
Mar 08What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates
Mar 04Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement
Jan 04Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target
Oct 04Voyager Therapeutics hires new finance chief
Sep 07Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02
Aug 04Looking Back In On Voyager Therapeutics
Jun 08Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates
May 12Voyager Does A Reboot After First Generation Failures
Mar 25Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky
Feb 07Voyager Therapeutics: Another Year, Another Deal
Nov 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 54 | -125 | -90 | -83 | 6 |
12/31/2025 | 56 | -119 | -117 | -111 | 9 |
12/31/2024 | 69 | -80 | -30 | -25 | 9 |
6/30/2024 | 144 | 9 | -22 | -18 | N/A |
3/31/2024 | 119 | -3 | 8 | 13 | N/A |
12/31/2023 | 250 | 132 | 75 | 78 | N/A |
9/30/2023 | 158 | 52 | 86 | 89 | N/A |
6/30/2023 | 195 | 96 | 91 | 94 | N/A |
3/31/2023 | 191 | 99 | 74 | 77 | N/A |
12/31/2022 | 41 | -46 | -15 | -13 | N/A |
9/30/2022 | 71 | -17 | 9 | 11 | N/A |
6/30/2022 | 31 | -60 | 4 | 6 | N/A |
3/31/2022 | 32 | -71 | 1 | 2 | N/A |
12/31/2021 | 37 | -71 | -55 | -54 | N/A |
9/30/2021 | 16 | -93 | -92 | -87 | N/A |
6/30/2021 | 132 | 18 | -100 | -91 | N/A |
3/31/2021 | 160 | 39 | -100 | -89 | N/A |
12/31/2020 | 171 | 37 | -109 | -97 | N/A |
9/30/2020 | 197 | 40 | -110 | -98 | N/A |
6/30/2020 | 100 | -61 | -103 | -95 | N/A |
3/31/2020 | 117 | -41 | -113 | -105 | N/A |
12/31/2019 | 104 | -44 | 41 | 49 | N/A |
9/30/2019 | 74 | -54 | 43 | 48 | N/A |
6/30/2019 | 55 | -59 | 47 | 52 | N/A |
3/31/2019 | 12 | -96 | 57 | 61 | N/A |
12/31/2018 | 8 | -88 | -20 | -16 | N/A |
9/30/2018 | 12 | -78 | -10 | -6 | N/A |
6/30/2018 | 11 | -81 | -8 | -5 | N/A |
3/31/2018 | 10 | -74 | N/A | 2 | N/A |
12/31/2017 | 10 | -71 | N/A | -61 | N/A |
9/30/2017 | 6 | -74 | N/A | -60 | N/A |
6/30/2017 | 8 | -59 | N/A | -54 | N/A |
3/31/2017 | 11 | -50 | N/A | -47 | N/A |
12/31/2016 | 14 | -40 | N/A | -42 | N/A |
9/30/2016 | 17 | -34 | N/A | -39 | N/A |
6/30/2016 | 18 | -32 | N/A | -36 | N/A |
3/31/2016 | 20 | -30 | N/A | -33 | N/A |
12/31/2015 | 17 | -38 | N/A | 41 | N/A |
9/30/2015 | 12 | -35 | N/A | 46 | N/A |
6/30/2015 | 7 | -32 | N/A | 50 | N/A |
3/31/2015 | 3 | -30 | N/A | 55 | N/A |
12/31/2014 | N/A | -18 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VYGR's earnings are forecast to decline over the next 3 years (-24% per year).
Earnings vs Market: VYGR's earnings are forecast to decline over the next 3 years (-24% per year).
High Growth Earnings: VYGR's earnings are forecast to decline over the next 3 years.